Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV single-arm multicenter study of Xiaoer Huanglong Granules in children with attention-deficit/hyperactivity disorder
CTR20160582Phase 4Active
- Sponsor
- Chongqing Hilan Pharmaceutical
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Xiao'er Huanglong Granules in attention deficit hyperactivity disorder (ADHD), sponsored by Chongqing Hilan Pharmaceutical. Started Nov 2016; status: active.
02
Drugs
Xiao'er Huanglong Granules
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on CTR20160582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160582.